ASJC Scopus subject areas
Access to Document
Other files and links
Multiplicity in oncology randomised controlled trials : a threat to medical evidence? / Prasad, Vinay; Booth, Christopher M.In: The Lancet Oncology, Vol. 20, No. 12, 12.2019, p. 1638-1640.
Research output: Contribution to journal › Comment/debate › peer-review
TY - JOUR
T1 - Multiplicity in oncology randomised controlled trials
T2 - a threat to medical evidence?
AU - Prasad, Vinay
AU - Booth, Christopher M.
N1 - Funding Information: VP is supported by the Arnold Foundation. CMB is supported as the Canada Research Chair in Population Cancer Care. We gratefully acknowledge Elizabeth Eisenhauer and Ian Tannock for comments on an earlier draft of this manuscript. VP reports receiving royalties from his book Ending Medical Reversal and an advance for the forthcoming book Malignant: How Bad Policy and Bad Evidence Work Against People With Cancer. VP's work is funded by the Laura and John Arnold Foundation and VP has received honoraria for Grand Rounds/lectures from several universities, medical centres, and professional societies and payments for contributions to Medscape. VP also hosts the podcast Plenary Session, which has Patreon backers. CMB declares no competing interests.
PY - 2019/12
Y1 - 2019/12
UR - http://www.scopus.com/inward/record.url?scp=85075648044&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075648044&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(19)30744-2
DO - 10.1016/S1470-2045(19)30744-2
M3 - Comment/debate
C2 - 31797779
AN - SCOPUS:85075648044
VL - 20
SP - 1638
EP - 1640
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 12